ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 124 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $361,000 | +30.3% | 5,000 | +19.0% | 0.11% | +29.4% |
| Q4 2017 | $277,000 | -81.9% | 4,200 | -86.3% | 0.08% | -76.5% |
| Q3 2017 | $1,533,000 | -64.8% | 30,600 | -67.5% | 0.36% | -63.7% |
| Q2 2017 | $4,356,000 | -65.6% | 94,118 | -73.7% | 0.99% | +29.4% |
| Q1 2017 | $12,658,000 | +20996.7% | 358,493 | +7316.1% | 0.77% | +38300.0% |
| Q4 2016 | $60,000 | +172.7% | 4,834 | +202.1% | 0.00% | +100.0% |
| Q3 2016 | $22,000 | +633.3% | 1,600 | +433.3% | 0.00% | – |
| Q2 2016 | $3,000 | -97.9% | 300 | -96.4% | 0.00% | -100.0% |
| Q1 2016 | $141,000 | +182.0% | 8,300 | +267.1% | 0.01% | +266.7% |
| Q4 2015 | $50,000 | +316.7% | 2,261 | +352.2% | 0.00% | +200.0% |
| Q3 2015 | $12,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,818,835 | $33,967,000 | 11.67% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,713,176 | $20,644,000 | 0.58% |
| Bellevue Group AG | 4,519,164 | $54,455,000 | 0.55% |
| Rhenman & Partners Asset Management AB | 622,267 | $7,498,000 | 0.53% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 47,534 | $573,000 | 0.21% |
| WASATCH ADVISORS LP | 3,274,360 | $39,456,000 | 0.16% |
| EMC Capital Management | 27,566 | $246,000 | 0.14% |
| PDT Partners, LLC | 120,828 | $1,456,000 | 0.10% |
| Virtus ETF Advisers LLC | 17,773 | $214,000 | 0.09% |
| Pinz Capital Management, LP | 15,300 | $184,000 | 0.08% |